SCHEMBL4735570

SCHEMBL4735570

N#Cc1ccc(C2CCN(C(=O)c3ccc(F)c(NC(=O)OCc4ccccc4)c3)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FASN P49327 20/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14161483 0.92 FASN (0.44) FASN
SCHEMBL4738019 0.90 FASN (0.53) FASN
SCHEMBL4736514 0.90 FASN (0.58) FASN
SCHEMBL4734941 0.88 FASN (0.53) FASN
SCHEMBL4733791 0.88 FASN (0.49) FASN
SCHEMBL4193677 0.85 FASN (0.56) FASN
SCHEMBL4734580 0.85 FASN (0.56) FASN
SCHEMBL4733786 0.85 FASN (0.51) FASN
SCHEMBL4738101 0.85 FASN (0.54) FASN
SCHEMBL4735386 0.83 FASN (0.52) FASN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008075077-A1 PIPERIDINE DERIVATIVES FOR THE TREATMENT OF OBESITY ASTRAZENECA AB (SE) 2008-06-26 WO claimed
WO-2008075077-A1 PIPERIDINE DERIVATIVES FOR THE TREATMENT OF OBESITY ASTRAZENECA AB (SE) 2008-06-26 WO disclosed